Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Long Term Debt 2012–2025
Coherus Biosciences Inc. annual/quarterly long term debt history from 2019 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Coherus Biosciences Inc. long term debt for the quarter ending December 31, 2019 were 73.7M.
- Coherus Biosciences Inc. long term debt for 2019 were 73.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Coherus Biosciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $74 |
| Coherus Biosciences Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2019-12-31 | $74 |
Coherus Biosciences Inc. Long Term Debt — FAQ
Coherus Biosciences Inc. (CHRS) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's long term debt history?
The chart and table above show Coherus Biosciences Inc.'s long term debt by year and by quarter, including the growth rate.